熱門資訊> 正文

Hefei BioPharma Corp. GAAP每股收益为C$-0.01

2026-03-18 00:06

HELIX ACQUISITION CORP.(HLXA) 0

Helix BioPharma Corp. press release (HBP:CA): Q2 GAAP EPS of C$-0.01.
Reported a net and total comprehensive loss from operations of C$0.7M in Q2 2026.
The Company had cash of C$0.03M as of January 31, 2026, down from C$2M at the end of the three months ended January 31, 2025.

More on Helix BioPharma Corp.

Financial information for Helix BioPharma Corp.

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。